6Brien C;Joshi S;Jordan J.Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis[J]Hepatology,2008(2):550-556.
7Grimbert S;Johanet C;Bendjaballah F.Antimitochondrial antibodies in patients with chronic hepatitis C[J]Liver,1996(3):161-165.
8Leung PS;Rossaro L;Davis PA.Antimitochondrial antibodies in acute liver failure:implications for primary biliary cirrhosis[J]Hepatology,2007(5):1436-1442.
9European Association for the Study of the Liver.EASL Clinical Practice Guidelines:management of cholestatic liver diseases[J]Journal of Hepatology,2009(02):237-267.
10Parés A;Caballeria L;Rodés J.Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid[J]Gastroenterology,2006(03):715-720.
6Manns MP,Czaja AJ,Gorham JD. Diagnosis and management of autoimmune hepatitis[J].Hepatology,2010.2193-2213.
7Lindor KD,Gershwin ME,Poupon R. Primary biliary cirrhosis[J].Hepatology,2009.291-308.
8Chapman R,Fevery J,Kalloo A. American Association for the Study of Liver Diseases Diagnosis and management of primary sclerosing cholangitis[J].Hepatology,2010.660-678.
9European Association for the Study of the Liver. EASL Clincal Practice Guidelines:Management of cholestatic Liver diseases[J].Journal of Hepatology,2009.237-267.
10Mendes FD,Lindor KD. Primary sclerosing cholangitis[J].Clinics in Liver Disease,2004.195-211.
